Gilad S. Gordon

2.7k citations
24 papers · 2.1k indexed · 1 hit paper · h-index 15
Topics
CAR-T cell therapy research (5 papers)Cutaneous lymphoproliferative disorders research (4 papers)Mosquito-borne diseases and control (3 papers)

In The Last Decade

Gilad S. Gordon

24 papers receiving 2.1k citations

Hit Papers

Costs, effects and C/E‐ratios alongside a clinical trial19942026200420151994250500750

Peers

Gilad S. Gordon
Comparison fields: 5 of 134
  • Molecular Biology 618
  • Economics and Econometrics 427
  • Oncology 388
  • Public Health, Environmental and Occupational Health 295
  • Infectious Diseases 212
Replace Richard B. Warren with:
Richard B. Warren United Kingdom
Alexis Ogdie United States
Rosa Parisi United Kingdom
Sara Rosenbaum United States
Steven Hirschfeld United States
David L. Cutler United States
Daniel B. Shin United States
Sarah Garner United Kingdom
T. Urban France
Valentina Orlando Italy
Gilad S. Gordon relative to Richard B. Warren United Kingdom Richard B. Warren's profile →
Citations per field
00.5×1.5×
Richard B. Warren · 1×
Citations per year

Countries citing papers authored by Gilad S. Gordon

Since Specialization
Citations

This map shows the geographic impact of Gilad S. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilad S. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilad S. Gordon more than expected).

Fields of papers citing papers by Gilad S. Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilad S. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilad S. Gordon. The network helps show where Gilad S. Gordon may publish in the future.

Co-authorship network of co-authors of Gilad S. Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of Gilad S. Gordon. A scholar is included among the top collaborators of Gilad S. Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilad S. Gordon. Gilad S. Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 4
3 2
4 14
5 2
6 5
7 14
8 25
9 49
10 64
11 115
12 26
13 14
14
Costs, effects and C/E‐ratios alongside a clinical trialbreakdown →
757
15 34
16
Charges for comprehensive obstetric care at teaching and nonteaching hospitals. A comparison.
1
17 6
18 255
19 15
20 23

About Gilad S. Gordon

Gilad S. Gordon is a scholar working on Family Practice, Dermatology and Oncology, having authored 24 papers that have together received 2.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Cutaneous lymphoproliferative disorders research (4 papers) and Mosquito-borne diseases and control (3 papers). The work is most often cited by research in Pharmaceutical Science (208 citations), Economics and Econometrics (427 citations) and Oncology (388 citations). Gilad S. Gordon has collaborated with scholars based in United States, Singapore and Colombia. Frequent co-authors include Maiwenn Al, Frans Rutten, Ben A. van Hout, Robert D. Silver, J S Flier, A C Moses, M C Carey, Jeffrey S. Flier, Alan C. Moses and Martin C. Carey. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026